Terveystalo aims to enhance its mental health service portfolio by acquiring Recuror Oy, a pioneer in psychiatric services and neuromodulation treatments.

Information on the Target

Terveystalo has announced its intention to acquire the entire share capital of Recuror Oy as of May 30, 2025. This strategic acquisition aims to enhance Terveystalo's mental health service portfolio, particularly in the cities of Turku and Helsinki, as well as expanding its offerings through digital platforms nationwide.

Founded in 2021, Recuror Oy is recognized for its specialized psychiatric services and is at the forefront of innovative neuromodulation treatments designed to address conditions such as depression and chronic pain. In the fiscal year 2024, Recuror achieved net sales amounting to €2.5 million, showcasing its potential for growth in the mental health sector.

Industry Overview in Finland

Finland's mental health services industry is evolving rapidly, driven by increasing awareness and acceptance of mental health issues among the population. The demand for mental health services has surged in recent years, high

View Source

Similar Deals

Hammas Hohde Oy Hammasklinikka Kruunu Oy

2025

Other Hospitals, Clinics & Primary Care Services Finland
PlusTerveys Hammasklinikat Oy Hyggan klinikkaliiketoiminta

2025

Other Hospitals, Clinics & Primary Care Services Finland
SpringWorks Therapeutics Rappta Therapeutics

2025

Other Bio Therapeutic Drugs Finland
Dexcom Oura

2022

Other Medical Software & Technology Services Finland
Mikeva Nurmela Kodit

2016

Other Residential & Long-Term Care Finland

Terveystalo

invested in

Recuror Oy

in 2025

in a Other deal

Disclosed details

Revenue: $3M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert